Ginkgo Bioworks shares are trading higher after the company and Texas A&M University announced they have been jointly awarded a research grant from the USDA APHIS via the NIFA AFRI to study SARS-CoV-2 in white-tailed deer populations in Texas.
Portfolio Pulse from Benzinga Newsdesk
Ginkgo Bioworks and Texas A&M University have been jointly awarded a research grant from the USDA APHIS via the NIFA AFRI to study SARS-CoV-2 in white-tailed deer populations in Texas. This news has led to an increase in Ginkgo Bioworks' share prices.
September 29, 2023 | 4:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ginkgo Bioworks' shares are trading higher after the company was awarded a research grant to study SARS-CoV-2 in deer populations in Texas.
The news of Ginkgo Bioworks receiving a research grant is a positive development for the company. This could potentially lead to new discoveries and advancements in their research, which could further enhance their reputation and increase investor confidence. This is likely the reason for the increase in their share prices.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100